The major objective of the Wisconsin Alzheimer's Disease Research Center's (ADRC) Administrative Core is to integrate and coordinate all the activities and components of the ADRC toward establishing an environment conducive to facilitating cutting-edge research in Alzheimer's disease (AD) and related illnesses, and provide state-of the-art clinical care to patients suffering from the devastations of dementia. The Core leadership will help the ADRC maintain its research focus on preclinical diagnosis and progression of AD, and ensure access of the Center resources and services to all the residents of the State of Wisconsin, including the underserved and underrepresented minority populations. The Core leadership has played a pivotal role in facilitating enormous growth and expansion of the AD research program at the UW, and will continue to provide new directions to the program. Additionally, under guidance from the External Advisory Board, the Core will help expand collaborative research between the ADRC investigators and those at other centers and institutions located both nationally and internationally. The Administrative Core will coordinate timely transmission of appropriate data to the National Alzheimer's Coordinating Center (NACC), and ensure compliance with all the federal, state and UW regulations related to human and animal research, Health Insurance Portability and Accountability Act (HIPAA), and data sharing and safety. The Core will oversee all the activities of the Pilot Research Program, including solicitation, review, and implementation of the projects. Overall, the Administrative Core will oversee and provide leadership to coordinate all the activities of the Wisconsin ADRC and ensure that it accomplishes all its major objectives and continues its journey toward preeminence in AD research.

Public Health Relevance

The Administrative Core of the Wisconsin ADRC will provide leadership and oversee all the major activities of the ADRC to ensure its continued success and a trajectory toward preeminence. The ADRC focuses on performing novel research toward identifying effective treatment and prevention strategies for Alzheimer's disease.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
United States
Zip Code
Brenowitz, Willa D; Keene, C Dirk; Hawes, Stephen E et al. (2017) Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. Neurobiol Aging 53:83-92
Law, Lena L; Schultz, Stephanie A; Boots, Elizabeth A et al. (2017) Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease. J Alzheimers Dis 56:351-359
Moga, Daniela C; Abner, Erin L; Wu, Qishan et al. (2017) Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement (N Y) 3:139-148
Katsumata, Yuriko; Nelson, Peter T; Ellingson, Sally R et al. (2017) Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. Neurobiol Aging 53:193.e17-193.e25
Dempsey, Robert J; Jackson, Daren C; Wilbrand, Stephanie M et al. (2017) The Preservation of Cognition 1 Yr After Carotid Endarterectomy in Patients With Prior Cognitive Decline. Neurosurgery :
Hullinger, Rikki; Puglielli, Luigi (2017) Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease. Behav Brain Res 322:191-205
Houlahan, Beth; Carlson, Elizabeth; Kind, Amy et al. (2017) Initiation of a Transitions Program: ""Two Million Melvins"". J Nurs Care Qual 32:99-103
Berman, Sara E; Clark, Lindsay R; Rivera-Rivera, Leonardo A et al. (2017) Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity. J Alzheimers Dis 60:243-252
Betthauser, Tobey J; Lao, Patrick J; Murali, Dhanabalan et al. (2017) In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317. J Nucl Med 58:996-1002
Hoy, Andrew R; Ly, Martina; Carlsson, Cynthia M et al. (2017) Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging. PLoS One 12:e0173982

Showing the most recent 10 out of 288 publications